Insulet Corporation (PODD): A Bull Case Theory [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
Insulet Corporation's share was trading at $255.81 as of January 30st. PODD's trailing and forward P/E were 74.37 and 41.84 respectively according to Yahoo Finance. Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. PODD is emerging as a high-quality growth company that has finally paired strong top-line momentum with disciplined cash management and balance sheet strength. The company sits on a robust liquidity position, with nearly $3 in current assets for every $1 of short-term obligations, supported by sharply accelerating cash generation. Operating cash flow surged to $430 million in 2024 from $146 million the prior year, while free cash flow jumped to $305 million, allowing Insulet to build a cash war chest of roughly $675 million. This financial inflection underpins the investment case as Insulet scales its flagship Omnipod system, a tubeless, wearable insulin pum
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding [Yahoo! Finance]Yahoo! Finance
- Insulet Launches Omnipod® 5 and Omnipod Discoverâ„¢ in the Middle East to Transform Diabetes CareBusiness Wire
- Insulet (NASDAQ:PODD) had its price target lowered by analysts at Stifel Nicolaus from $370.00 to $350.00. They now have a "buy" rating on the stock.MarketBeat
- Reasons Why Hedge Funds Favor Insulet Corp (PODD) [Yahoo! Finance]Yahoo! Finance
- Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And Growth Expectations [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 2/5/26 - Form SCHEDULE
- 2/3/26 - Form 8-K
- 1/6/26 - Form 4
- PODD's page on the SEC website